BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9528717)

  • 1. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients.
    Linpiyawan R; Jittreprasert K; Sivayathorn A
    Int J Dermatol; 2000 Nov; 39(11):859-61. PubMed ID: 11123451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
    Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in aids patients.
    Queiroz-Telles F; Silva N; Carvalho MM; Alcântara AP; da Matta D; Barberino MG; Bartczak S; Colombo AL
    Braz J Infect Dis; 2001 Apr; 5(2):60-6. PubMed ID: 11493410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis.
    Nairy HM; Charyulu NR; Shetty VA; Prabhakara P
    Trials; 2011 Apr; 12():99. PubMed ID: 21504616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
    Koks CH; Meenhorst PL; Bult A; Beijnen JH
    Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.
    Murray PA; Koletar SL; Mallegol I; Wu J; Moskovitz BL
    Clin Ther; 1997; 19(3):471-80. PubMed ID: 9220211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
    Wilcox CM; Darouiche RO; Laine L; Moskovitz BL; Mallegol I; Wu J
    J Infect Dis; 1997 Jul; 176(1):227-32. PubMed ID: 9207371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
    Studena V; Sycova Z; Helpianska L; Sorkovska D; Pichna P; Lacka J; Hlavacova E; Oravcova E; Krcmery V; Studena M
    J Chemother; 1995 Nov; 7 Suppl 4():204-5. PubMed ID: 8904157
    [No Abstract]   [Full Text] [Related]  

  • 20. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.